Longevity News

Claremedica’s digital test finds 90% of new dementia cases early

Source: Longevity Technology • Published: 27 Aug 2026, 15:00

Claremedica’s digital test finds 90% of new dementia cases early

A report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.

Key Takeaways
  • Cognitive decline is often the one vital sign primary care does not routinely check
  • Perhaps the most telling detail in Claremedica’s data is not the patients who were never screened
  • Claremedica had used the MMSE organization-wide for more than two years before switching to Creyos
Read Original Source

Continue exploring

Related longevity signals

Longevity TechnologyUtah is building America’s longevity capitalA look at how a regional mix of clinics, consumer brands, and wellness tech is turning Utah into a practical longevity economy.Longevity TechnologyTelehealth longevity platform among XPRIZE Healthspan’s top 10A profile of a telehealth-first longevity provider that earned a Milestone 2 award in the XPRIZE Healthspan competition and plans larger trials.Longevity TechnologyResbiotic takes microbiome science and longevity to grocery aislesA consumer-health story about a physician-founded microbiome brand bringing prebiotic and probiotic products from scientific development into mainstream grocery retail.Longevity TechnologyUK beats EU and US to first oral GLP-1 approvalOrforglipron’s UK authorization is covered in a regulatory-first roundup, explaining what this approval milestone means for patients and market access.